Irlandia - angielski - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - sodium chloride; glucose monohydrate ph. eur.; sodium acetate, trihydrate; potassium chloride ph. eur.; magnesium chloride hexahydrate ph. eur. - solution for infusion - 55.00 gram(s)/litre - electrolytes with carbohydrates

Malta - angielski - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - glucose monohydrate - solution for infusion - glucose monohydrate 50 g/l - blood substitutes and perfusion solutions

Malta - angielski - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, potassium chloride, sodium chloride - solution for infusion - sodium chloride 8.6 g/l potassium chloride 0.3 g/l calcium chloride dihydrate 0.33 g/l - blood substitutes and perfusion solutions

Malta - angielski - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium gluconate - solution for infusion - sodium chloride 5.26 g/l potassium chloride 0.37 g/l magnesium chloride hexahydrate 0.30 g/l sodium acetate trihydrate 3.68 g/l sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

Malta - angielski - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium chloride, potassium chloride, magnesium chloride, hexahydrate, sodium acetate, trihydrate, sodium gluconate - solution for infusion - potassium chloride 0.37 g/l magnesium chloride hexahydrate 0.30 g/l sodium acetate trihydrate 3.68 g/l sodium gluconate 5.02 g/l sodium chloride 5.26 g/l - blood substitutes and perfusion solutions

Izrael - angielski - Ministry of Health

abic marketing ltd, israel - pemetrexed - powder for concentrate for solution for infusion - pemetrexed 100 mg - pemetrexed - malignant pleural mesothelioma :pemetrexed teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. non-small cell lung cancer: pemetrexed teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Izrael - angielski - Ministry of Health

abic marketing ltd, israel - pemetrexed - powder for concentrate for solution for infusion - pemetrexed 1000 mg - pemetrexed - malignant pleural mesothelioma :pemetrexed teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. non-small cell lung cancer: pemetrexed teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Izrael - angielski - Ministry of Health

abic marketing ltd, israel - pemetrexed - powder for concentrate for solution for infusion - pemetrexed 500 mg - pemetrexed - malignant pleural mesothelioma :pemetrexed teva in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curatible surgery. non-small cell lung cancer: pemetrexed teva in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed teva is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed teva is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Malta - angielski - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - calcium chloride dihydrate 0.27 g/l potassium chloride 0.4 g/l sodium chloride 6 g/l sodium lactate 3.2 g/l - blood substitutes and perfusion solutions

Malta - angielski - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - glucose, sodium chloride - solution for infusion - glucose 5 % (w/v) sodium chloride 0.45 % (w/v) - blood substitutes and perfusion solutions